Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 5

Home > Reports > Medical Devices & Consumables > Prostate Cancer Antigen 3 Test - Global Market Insights and Sales Trends 2024

Prostate Cancer Antigen 3 Test - Global Market Insights and Sales Trends 2024

Prostate Cancer Antigen 3 Test - Global Market Insights and Sales Trends 2024

Industry: Medical Devices & Consumables

Published: 2023-12-29

Pages: 101 Pages

Report ld: 2078209

申请样本

Request Sample

定制报告

Pre-Order Enquiry

申请样本

Request Sample

定制报告

Pre-Order Enquiry

  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中

Description

The prostate cancer antigen 3 gene (PCA3) test is used to assess your risk of developing prostate cancer. It is not used to make a diagnosis of prostate cancer. It is primarily used to determine whether your elevated prostate-specific antigen (PSA) levels are the result of prostate cancer. Prostate cancer is a type of cancer that develops in the prostate gland of men and is increasing at a significant rate each year. This cancer is commonly found in the elderly population, and it can have serious consequences such as blood in the sperm, bone pain, and erectile dysfunction, among others. As a result, early detection is required to avoid it at an early stage.

The global Prostate Cancer Antigen 3 Test market size is expected to reach US$ 4112.5 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate Cancer Antigen 3 Test in various end use industries. The expanding demands from the Hospital, Specialist Clinic and Other,, are propelling Prostate Cancer Antigen 3 Test market. RT-PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ELISA Test segment is estimated at % CAGR for the next seven-year period.

Prostate Cancer Antigen 3 Test Market Size

M= millions and B=billions

QYRLogo
Asia Pacific shows high growth potential for Prostate Cancer Antigen 3 Test market, driven by demand from China, the second largest economy with some signs of stabilising, the Prostate Cancer Antigen 3 Test market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate Cancer Antigen 3 Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:
This report provides in-depth analysis of the global Prostate Cancer Antigen 3 Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Prostate Cancer Antigen 3 Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate Cancer Antigen 3 Test sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Prostate Cancer Antigen 3 Test covered in this report include MDxHealth, Myriad Genetics, Inc, Abbott, F. Hoffmann-La Roche Ltd, Siemens, OPKO Health, Inc, Genomic Health, BD and Agilent Technologies, Inc, etc.

The global Prostate Cancer Antigen 3 Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Prostate Cancer Antigen 3 Test - Global Market Insights and Sales Trends 2024

  • Forecasted Market Size in 2029

  • US$ 4112.5 million

  • CAGR(2023-2029)

  • 7.9%

  • Market Size Available for Years

  • 2018-2029

  • Global Prostate Cancer Antigen 3 Test Companies Covered

  • MDxHealth, Myriad Genetics, Inc, Abbott, F. Hoffmann-La Roche Ltd, Siemens, OPKO Health, Inc, Genomic Health, BD, Agilent Technologies, Inc, Danaher

  • Global Prostate Cancer Antigen 3 Test Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Prostate Cancer Antigen 3 Test Market, Segment by Type

  • RT-PCR

    ELISA Test

    Micro-neutralization Assays

  • Global Prostate Cancer Antigen 3 Test Market, Segment by Application

  • Hospital

    Specialist Clinic

    Other

  • Forecast Units

  • USD million in value

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate Cancer Antigen 3 Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Table of Contents

 1 Market Overview of Prostate Cancer Antigen 3 Test
    1.1 Prostate Cancer Antigen 3 Test Market Overview
        1.1.1 Prostate Cancer Antigen 3 Test Product Scope
        1.1.2 Prostate Cancer Antigen 3 Test Market Status and Outlook
    1.2 Global Prostate Cancer Antigen 3 Test Market Size Overview by Region 2018 VS 2022 VS 2029
    1.3 Global Prostate Cancer Antigen 3 Test Market Size by Region (2018-2029)
    1.4 Global Prostate Cancer Antigen 3 Test Historic Market Size by Region (2018-2023)
    1.5 Global Prostate Cancer Antigen 3 Test Market Size Forecast by Region (2024-2029)
    1.6 Key Regions, Prostate Cancer Antigen 3 Test Market Size (2018-2029)
        1.6.1 North America Prostate Cancer Antigen 3 Test Market Size (2018-2029)
        1.6.2 Europe Prostate Cancer Antigen 3 Test Market Size (2018-2029)
        1.6.3 Asia-Pacific Prostate Cancer Antigen 3 Test Market Size (2018-2029)
        1.6.4 Latin America Prostate Cancer Antigen 3 Test Market Size (2018-2029)
        1.6.5 Middle East & Africa Prostate Cancer Antigen 3 Test Market Size (2018-2029)

 2 Prostate Cancer Antigen 3 Test Market by Type
    2.1 Introduction
        2.1.1 RT-PCR
        2.1.2 ELISA Test
        2.1.3 Micro-neutralization Assays
    2.2 Global Prostate Cancer Antigen 3 Test Market Size by Type: 2018 VS 2022 VS 2029
        2.2.1 Global Prostate Cancer Antigen 3 Test Historic Market Size by Type (2018-2023)
        2.2.2 Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Type (2024-2029)
    2.3 Key Regions Market Size by Type
        2.3.1 North America Prostate Cancer Antigen 3 Test Revenue Breakdown by Type (2018-2029)
        2.3.2 Europe Prostate Cancer Antigen 3 Test Revenue Breakdown by Type (2018-2029)
        2.3.3 Asia-Pacific Prostate Cancer Antigen 3 Test Revenue Breakdown by Type (2018-2029)
        2.3.4 Latin America Prostate Cancer Antigen 3 Test Revenue Breakdown by Type (2018-2029)
        2.3.5 Middle East and Africa Prostate Cancer Antigen 3 Test Revenue Breakdown by Type (2018-2029)

 3 Prostate Cancer Antigen 3 Test Market Overview by Application
    3.1 Introduction
        3.1.1 Hospital
        3.1.2 Specialist Clinic
        3.1.3 Other
    3.2 Global Prostate Cancer Antigen 3 Test Market Size by Application: 2018 VS 2022 VS 2029
        3.2.1 Global Prostate Cancer Antigen 3 Test Historic Market Size by Application (2018-2023)
        3.2.2 Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Application (2024-2029)
    3.3 Key Regions Market Size by Application
        3.3.1 North America Prostate Cancer Antigen 3 Test Revenue Breakdown by Application (2018-2029)
        3.3.2 Europe Prostate Cancer Antigen 3 Test Revenue Breakdown by Application (2018-2029)
        3.3.3 Asia-Pacific Prostate Cancer Antigen 3 Test Revenue Breakdown by Application (2018-2029)
        3.3.4 Latin America Prostate Cancer Antigen 3 Test Revenue Breakdown by Application (2018-2029)
        3.3.5 Middle East and Africa Prostate Cancer Antigen 3 Test Revenue Breakdown by Application (2018-2029)

 4 Prostate Cancer Antigen 3 Test Competition Analysis by Players
    4.1 Global Prostate Cancer Antigen 3 Test Market Size by Players (2018-2023)
    4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Antigen 3 Test as of 2022)
    4.3 Date of Key Players Enter into Prostate Cancer Antigen 3 Test Market
    4.4 Global Top Players Prostate Cancer Antigen 3 Test Headquarters and Area Served
    4.5 Key Players Prostate Cancer Antigen 3 Test Product Solution and Service
    4.6 Competitive Status
        4.6.1 Prostate Cancer Antigen 3 Test Market Concentration Rate
        4.6.2 Mergers & Acquisitions, Expansion Plans

 5 Company (Top Players) Profiles
    5.1 MDxHealth
        5.1.1 MDxHealth Profile
        5.1.2 MDxHealth Main Business
        5.1.3 MDxHealth Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.1.4 MDxHealth Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.1.5 MDxHealth Recent Developments
    5.2 Myriad Genetics, Inc
        5.2.1 Myriad Genetics, Inc Profile
        5.2.2 Myriad Genetics, Inc Main Business
        5.2.3 Myriad Genetics, Inc Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.2.4 Myriad Genetics, Inc Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.2.5 Myriad Genetics, Inc Recent Developments
    5.3 Abbott
        5.3.1 Abbott Profile
        5.3.2 Abbott Main Business
        5.3.3 Abbott Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.3.4 Abbott Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.3.5 F. Hoffmann-La Roche Ltd Recent Developments
    5.4 F. Hoffmann-La Roche Ltd
        5.4.1 F. Hoffmann-La Roche Ltd Profile
        5.4.2 F. Hoffmann-La Roche Ltd Main Business
        5.4.3 F. Hoffmann-La Roche Ltd Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.4.4 F. Hoffmann-La Roche Ltd Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.4.5 F. Hoffmann-La Roche Ltd Recent Developments
    5.5 Siemens
        5.5.1 Siemens Profile
        5.5.2 Siemens Main Business
        5.5.3 Siemens Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.5.4 Siemens Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.5.5 Siemens Recent Developments
    5.6 OPKO Health, Inc
        5.6.1 OPKO Health, Inc Profile
        5.6.2 OPKO Health, Inc Main Business
        5.6.3 OPKO Health, Inc Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.6.4 OPKO Health, Inc Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.6.5 OPKO Health, Inc Recent Developments
    5.7 Genomic Health
        5.7.1 Genomic Health Profile
        5.7.2 Genomic Health Main Business
        5.7.3 Genomic Health Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.7.4 Genomic Health Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.7.5 Genomic Health Recent Developments
    5.8 BD
        5.8.1 BD Profile
        5.8.2 BD Main Business
        5.8.3 BD Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.8.4 BD Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.8.5 BD Recent Developments
    5.9 Agilent Technologies, Inc
        5.9.1 Agilent Technologies, Inc Profile
        5.9.2 Agilent Technologies, Inc Main Business
        5.9.3 Agilent Technologies, Inc Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.9.4 Agilent Technologies, Inc Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.9.5 Agilent Technologies, Inc Recent Developments
    5.10 Danaher
        5.10.1 Danaher Profile
        5.10.2 Danaher Main Business
        5.10.3 Danaher Prostate Cancer Antigen 3 Test Products, Services and Solutions
        5.10.4 Danaher Prostate Cancer Antigen 3 Test Revenue (US$ Million) & (2018-2023)
        5.10.5 Danaher Recent Developments

 6 North America
    6.1 North America Prostate Cancer Antigen 3 Test Market Size by Country (2018-2029)
    6.2 United States
    6.3 Canada

 7 Europe
    7.1 Europe Prostate Cancer Antigen 3 Test Market Size by Country (2018-2029)
    7.2 Germany
    7.3 France
    7.4 U.K.
    7.5 Italy
    7.6 Russia
    7.7 Nordic Countries
    7.8 Rest of Europe

 8 Asia-Pacific
    8.1 Asia-Pacific Prostate Cancer Antigen 3 Test Market Size by Region (2018-2029)
    8.2 China
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australia
    8.8 Rest of Asia-Pacific

 9 Latin America
    9.1 Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2018-2029)
    9.2 Mexico
    9.3 Brazil
    9.4 Rest of Latin America

 10 Middle East & Africa
    10.1 Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Country (2018-2029)
    10.2 Turkey
    10.3 Saudi Arabia
    10.4 UAE
    10.5 Rest of Middle East & Africa

 11 Prostate Cancer Antigen 3 Test Market Dynamics
    11.1 Prostate Cancer Antigen 3 Test Industry Trends
    11.2 Prostate Cancer Antigen 3 Test Market Drivers
    11.3 Prostate Cancer Antigen 3 Test Market Challenges
    11.4 Prostate Cancer Antigen 3 Test Market Restraints

 12 Research Finding /Conclusion

 13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List

Table of Figures

List of Tables
    Table 1. Global Market Prostate Cancer Antigen 3 Test Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Prostate Cancer Antigen 3 Test Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Prostate Cancer Antigen 3 Test Market Size Share by Region (2018-2023)
    Table 4. Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Prostate Cancer Antigen 3 Test Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Prostate Cancer Antigen 3 Test Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Prostate Cancer Antigen 3 Test Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Prostate Cancer Antigen 3 Test Revenue Market Share by Type (2018-2023)
    Table 9. Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Prostate Cancer Antigen 3 Test Revenue Market Share by Type (2024-2029)
    Table 11. North America Prostate Cancer Antigen 3 Test Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Prostate Cancer Antigen 3 Test Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Prostate Cancer Antigen 3 Test Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Prostate Cancer Antigen 3 Test Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Prostate Cancer Antigen 3 Test Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Prostate Cancer Antigen 3 Test Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Prostate Cancer Antigen 3 Test Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Prostate Cancer Antigen 3 Test Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Prostate Cancer Antigen 3 Test Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Prostate Cancer Antigen 3 Test Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Prostate Cancer Antigen 3 Test Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Prostate Cancer Antigen 3 Test Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Prostate Cancer Antigen 3 Test Revenue Market Share by Application (2018-2023)
    Table 24. Global Prostate Cancer Antigen 3 Test Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Prostate Cancer Antigen 3 Test Revenue Market Share by Application (2024-2029)
    Table 26. North America Prostate Cancer Antigen 3 Test Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Prostate Cancer Antigen 3 Test Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Prostate Cancer Antigen 3 Test Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Prostate Cancer Antigen 3 Test Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Prostate Cancer Antigen 3 Test Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Prostate Cancer Antigen 3 Test Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Prostate Cancer Antigen 3 Test Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Prostate Cancer Antigen 3 Test Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Prostate Cancer Antigen 3 Test Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Prostate Cancer Antigen 3 Test Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Prostate Cancer Antigen 3 Test Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Prostate Cancer Antigen 3 Test Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Antigen 3 Test as of 2022)
    Table 39. Date of Key Players Enter into Prostate Cancer Antigen 3 Test Market
    Table 40. Global Prostate Cancer Antigen 3 Test Key Players Headquarters and Area Served
    Table 41. Prostate Cancer Antigen 3 Test Product Solution and Service
    Table 42. Global Prostate Cancer Antigen 3 Test Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. MDxHealth Basic Information List
    Table 45. MDxHealth Description and Business Overview
    Table 46. MDxHealth Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of MDxHealth (2018-2023)
    Table 48. MDxHealth Recent Developments
    Table 49. Myriad Genetics, Inc Basic Information List
    Table 50. Myriad Genetics, Inc Description and Business Overview
    Table 51. Myriad Genetics, Inc Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of Myriad Genetics, Inc (2018-2023)
    Table 53. Myriad Genetics, Inc Recent Developments
    Table 54. Abbott Basic Information List
    Table 55. Abbott Description and Business Overview
    Table 56. Abbott Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of Abbott (2018-2023)
    Table 58. Abbott Recent Developments
    Table 59. F. Hoffmann-La Roche Ltd Basic Information List
    Table 60. F. Hoffmann-La Roche Ltd Description and Business Overview
    Table 61. F. Hoffmann-La Roche Ltd Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of F. Hoffmann-La Roche Ltd (2018-2023)
    Table 63. F. Hoffmann-La Roche Ltd Recent Developments
    Table 64. Siemens Basic Information List
    Table 65. Siemens Description and Business Overview
    Table 66. Siemens Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of Siemens (2018-2023)
    Table 68. Siemens Recent Developments
    Table 69. OPKO Health, Inc Basic Information List
    Table 70. OPKO Health, Inc Description and Business Overview
    Table 71. OPKO Health, Inc Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of OPKO Health, Inc (2018-2023)
    Table 73. OPKO Health, Inc Recent Developments
    Table 74. Genomic Health Basic Information List
    Table 75. Genomic Health Description and Business Overview
    Table 76. Genomic Health Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of Genomic Health (2018-2023)
    Table 78. Genomic Health Recent Developments
    Table 79. BD Basic Information List
    Table 80. BD Description and Business Overview
    Table 81. BD Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of BD (2018-2023)
    Table 83. BD Recent Developments
    Table 84. Agilent Technologies, Inc Basic Information List
    Table 85. Agilent Technologies, Inc Description and Business Overview
    Table 86. Agilent Technologies, Inc Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of Agilent Technologies, Inc (2018-2023)
    Table 88. Agilent Technologies, Inc Recent Developments
    Table 89. Danaher Basic Information List
    Table 90. Danaher Description and Business Overview
    Table 91. Danaher Prostate Cancer Antigen 3 Test Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Prostate Cancer Antigen 3 Test Business of Danaher (2018-2023)
    Table 93. Danaher Recent Developments
    Table 94. North America Prostate Cancer Antigen 3 Test Market Size by Country (2018-2023) & (US$ Million)
    Table 95. North America Prostate Cancer Antigen 3 Test Market Size by Country (2024-2029) & (US$ Million)
    Table 96. Europe Prostate Cancer Antigen 3 Test Market Size by Country (2018-2023) & (US$ Million)
    Table 97. Europe Prostate Cancer Antigen 3 Test Market Size by Country (2024-2029) & (US$ Million)
    Table 98. Asia-Pacific Prostate Cancer Antigen 3 Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 99. Asia-Pacific Prostate Cancer Antigen 3 Test Market Size by Region (2018-2023) & (US$ Million)
    Table 100. Asia-Pacific Prostate Cancer Antigen 3 Test Market Size by Region (2024-2029) & (US$ Million)
    Table 101. Asia-Pacific Prostate Cancer Antigen 3 Test Market Share by Region (2018-2023)
    Table 102. Asia-Pacific Prostate Cancer Antigen 3 Test Market Share by Region (2024-2029)
    Table 103. Latin America Prostate Cancer Antigen 3 Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 104. Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2018-2023) & (US$ Million)
    Table 105. Latin America Prostate Cancer Antigen 3 Test Market Size by Country (2024-2029) & (US$ Million)
    Table 106. Middle East & Africa Prostate Cancer Antigen 3 Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 107. Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Country (2018-2023) & (US$ Million)
    Table 108. Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Country (2024-2029) & (US$ Million)
    Table 109. Prostate Cancer Antigen 3 Test Market Trends
    Table 110. Prostate Cancer Antigen 3 Test Market Drivers
    Table 111. Prostate Cancer Antigen 3 Test Market Challenges
    Table 112. Prostate Cancer Antigen 3 Test Market Restraints
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Antigen 3 Test Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Prostate Cancer Antigen 3 Test Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Prostate Cancer Antigen 3 Test Market Share by Regions: 2022 VS 2029
    Figure 4. Global Prostate Cancer Antigen 3 Test Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Prostate Cancer Antigen 3 Test Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Prostate Cancer Antigen 3 Test Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Prostate Cancer Antigen 3 Test Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Prostate Cancer Antigen 3 Test Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Prostate Cancer Antigen 3 Test Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of RT-PCR
    Figure 11. Global RT-PCR Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of ELISA Test
    Figure 13. Global ELISA Test Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Micro-neutralization Assays
    Figure 15. Global Micro-neutralization Assays Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Global Prostate Cancer Antigen 3 Test Market Size Share by Type:  2022 & 2029
    Figure 17. North America Prostate Cancer Antigen 3 Test Revenue Market Share by Type (2018-2029)
    Figure 18. Europe Prostate Cancer Antigen 3 Test Revenue Market Share by Type (2018-2029)
    Figure 19. Asia-Pacific Prostate Cancer Antigen 3 Test Revenue Market Share by Type (2018-2029)
    Figure 20. Latin America Prostate Cancer Antigen 3 Test Revenue Market Share by Type (2018-2029)
    Figure 21. Middle East and Africa Prostate Cancer Antigen 3 Test Revenue Market Share by Type (2018-2029)
    Figure 22. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Specialist Clinic Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Other Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Global Prostate Cancer Antigen 3 Test Market Size Share by Application: 2022 & 2029
    Figure 26. North America Prostate Cancer Antigen 3 Test Revenue Market Share by Application (2018-2029)
    Figure 27. Europe Prostate Cancer Antigen 3 Test Revenue Market Share by Application (2018-2029)
    Figure 28. Asia-Pacific Prostate Cancer Antigen 3 Test Revenue Market Share by Application (2018-2029)
    Figure 29. Latin America Prostate Cancer Antigen 3 Test Revenue Market Share by Application (2018-2029)
    Figure 30. Middle East and Africa Prostate Cancer Antigen 3 Test Revenue Market Share by Application (2018-2029)
    Figure 31. Prostate Cancer Antigen 3 Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 32. Global Top 5 and Top 10 Players Prostate Cancer Antigen 3 Test Market Share in 2022
    Figure 33. North America Prostate Cancer Antigen 3 Test Market Share by Country (2018-2029)
    Figure 34. United States Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 35. Canada Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 36. Germany Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 37. France Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 38. U.K. Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 39. Italy Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 40. Russia Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 41. Nordic Countries Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 42. Asia-Pacific Prostate Cancer Antigen 3 Test Market Share by Region (2018-2029)
    Figure 43. China Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 44. Japan Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 45. South Korea Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 46. Southeast Asia Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 47. India Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 48. Australia Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 49. Latin America Prostate Cancer Antigen 3 Test Market Share by Country (2018-2029)
    Figure 50. Mexico Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 51. Brazil Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 52. Middle East & Africa Prostate Cancer Antigen 3 Test Market Share by Country (2018-2029)
    Figure 53. Turkey Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 55. UAE Prostate Cancer Antigen 3 Test Market Size (2018-2029) & (US$ Million)
    Figure 56. Bottom-up and Top-down Approaches for This Report

Description

The prostate cancer antigen 3 gene (PCA3) test is used to assess your risk of developing prostate cancer. It is not used to make a diagnosis of prostate cancer. It is primarily used to determine whether your elevated prostate-specific antigen (PSA) levels are the result of prostate cancer. Prostate cancer is a type of cancer that develops in the prostate gland of men and is increasing at a significant rate each year. This cancer is commonly found in the elderly population, and it can have serious consequences such as blood in the sperm, bone pain, and erectile dysfunction, among others. As a result, early detection is required to avoid it at an early stage.

The global Prostate Cancer Antigen 3 Test market size is expected to reach US$ 4112.5 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate Cancer Antigen 3 Test in various end use industries. The expanding demands from the Hospital, Specialist Clinic and Other,, are propelling Prostate Cancer Antigen 3 Test market. RT-PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ELISA Test segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Prostate Cancer Antigen 3 Test market, driven by demand from China, the second largest economy with some signs of stabilising, the Prostate Cancer Antigen 3 Test market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate Cancer Antigen 3 Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:
This report provides in-depth analysis of the global Prostate Cancer Antigen 3 Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Prostate Cancer Antigen 3 Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate Cancer Antigen 3 Test sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Prostate Cancer Antigen 3 Test covered in this report include MDxHealth, Myriad Genetics, Inc, Abbott, F. Hoffmann-La Roche Ltd, Siemens, OPKO Health, Inc, Genomic Health, BD and Agilent Technologies, Inc, etc.

The global Prostate Cancer Antigen 3 Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate Cancer Antigen 3 Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Prostate Cancer Antigen 3 Test - Global Market Insights and Sales Trends 2024

Industry: Medical Devices & Consumables

Published: 2023-12-29

Pages: 101 Pages

Report ld: 2078209

申请样本

Request Sample

定制报告

Pre-Order Enquiry

CHOOSE LICENSE TYPE
提示

USD 3350.00

提示

USD 5025.00

提示

USD 6700.00

/uploads/payment/payIcon/masterCard-01.svg/uploads/payment/payIcon/visa-01.svg/uploads/payment/payIcon/diners-club-01.svg/uploads/payment/payIcon/discover-4-01.svg/uploads/payment/payIcon/jcb-01.svg/uploads/payment/paypal.webp
加入购物车

Add to Cart

立即购买

Buy Now

Have a question?
Simon Lee

English

English

Simon Lee

+1-62 6295 2442

Hitesh

English

English

Hitesh

+91-86 6998 6909

Damon

Chinese

Chinese

Damon

+86-133 1872 9947

Tang Xin

Japanese

Japanese

Tang Xin

+81-90 3800 9273

Sung-Bin Yoon

Korean

Korean

Sung-Bin Yoon

+82-2883 1278

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

Have a question?
Simon Lee

English

English

Simon Lee

+1-62 6295 2442

Hitesh

English

English

Hitesh

+91-86 6998 6909

Damon

Chinese

Chinese

Damon

+86-133 1872 9947

Tang Xin

Japanese

Japanese

Tang Xin

+81-90 3800 9273

Sung-Bin Yoon

Korean

Korean

Sung-Bin Yoon

+82-2883 1278

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

加入购物车

Add to Cart

立即购买

Buy Now